Four Korean-Founded US Biotechs Eye KOSDAQ Listings
Four US-based biotech ventures founded by Korean scientists—Ingenia, BreezeBio, Pinetree and Kyzen—are pursuing KOSDAQ listings via Korean Depositary Receipts, with Ingenia launching its public…
Read the full articleYou might also wanna read
Basel Area Business & Innovation partners with Korean biopharma firms Roche Korea, KHIDI, and KIBO
Basel Area Business & Innovation inks new collaboration with Korean biopharma companies
biospectrumasia.com·1mo ago
South Korea’s AimedBio Invests in Inocras, Partners on WGS for Cancer Trials
The companies hope to find patients likely to respond to AimedBio’s antibody-drug conjugates.
Greater Bay Area emerges as launchpad for China's biotech rise
GUANGZHOU, July 3 (Xinhua) -- In the humid heat of July in southern China, the Akeso Greater Bay Area Technology Park in Zhongshan, Guangdon
Orchid CEO Noor Siddiqui on genetic embryo screening, controversy, and 'stacking the deck' for healthier babies
The category creator in reproductive health talks 'superbabies,' Thiel Fellows and startup 'holy wars' on the Upstarts Podcast.
upstartsmedia.com·1mo agoSouth Korea’s SK Hynix raises $26.5bn in record-breaking US IPO
South Korean chip giant makes largest-ever debut by a foreign firm in the US, eclipsing Alibaba's 2014 IPO.
Biogen Is Paying $1 Billion for a Company That Won't Say What It Makes. Here's Why That's Actually Good News for BIIB Investors.
This could be a key move for future growth.
Comments
Sign in to join the conversation.
No comments yet. Be the first.